| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/25/2012 | EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists |
| 07/25/2012 | EP2477981A1 Heterocyclic mglu5 antagonists |
| 07/25/2012 | EP2477979A1 Compounds for organic light emitting diode emissive layers |
| 07/25/2012 | EP2477976A1 Quinazolinone derivatives as viral polymerase inhibitors |
| 07/25/2012 | EP2477498A1 Inhibitors of diacylglycerol acyltransferase |
| 07/25/2012 | EP2205558B1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 07/25/2012 | EP2013201B1 Heterocyclic gpcr agonists |
| 07/25/2012 | EP1940393B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/25/2012 | EP1891063B1 Bicyclic derivatives as modulators of ion channels |
| 07/25/2012 | EP1891019B1 2,6-substituted-4-monosubstitutedamino-pyrimidines as prostaglandin d2 receptor antagonists |
| 07/25/2012 | EP1723121B1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
| 07/25/2012 | EP1699783B1 Opioid receptor antagonists |
| 07/25/2012 | EP1622866B1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 07/25/2012 | CN102603725A Near-infrared fluorescence probe used for detecting zinc ions in water phase, preparation method thereof, and application thereof |
| 07/25/2012 | CN102603724A Method for purifying and refining dimethoxy taxane compound |
| 07/25/2012 | CN102603723A Azilsartan organic amine salts, and preparation method and application thereof |
| 07/25/2012 | CN102603695A Amino acid-fluorophore compound and application thereof |
| 07/25/2012 | CN101921266B 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof |
| 07/25/2012 | CN101868456B Pyridine compound, pesticidal composition and method of controlling pest |
| 07/25/2012 | CN101475573B Anti-influenza medicament Tamiflu intermediate, synthesizing method and use thereof |
| 07/25/2012 | CN101268046B Carboxamide derivatives as muscarinic receptor antagonists |
| 07/24/2012 | US8227494 Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease |
| 07/24/2012 | US8227488 Injectable depot formulation comprising crystals of iloperidone |
| 07/24/2012 | US8227485 Benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 07/24/2012 | US8227469 Vanilloid receptor ligands and their use in treatments |
| 07/24/2012 | US8227467 Therapeutic agents useful for treating pain |
| 07/24/2012 | US8227463 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 07/24/2012 | US8227461 Isoxazoles |
| 07/24/2012 | CA2663044C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same |
| 07/24/2012 | CA2526082C Triazole-derivatives as factor xa inhibitors |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 07/19/2012 | WO2012097273A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea |
| 07/19/2012 | WO2012095803A1 New fluorescent compounds |
| 07/19/2012 | WO2012095469A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
| 07/19/2012 | WO2012095463A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 07/19/2012 | WO2012095451A1 Crystalline oxazine derivative and its use as bace inhibitor |
| 07/19/2012 | WO2012070015A9 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases |
| 07/19/2012 | WO2012065904A3 Cyanoenamines and their use as fungicides |
| 07/19/2012 | WO2012059441A3 Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes |
| 07/19/2012 | US20120184737 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 07/19/2012 | US20120184736 Method for producing a 3-(substituted-oxy)-4-pyridazinol derivative |
| 07/19/2012 | US20120184583 Modulators of atp-binding cassette transporters |
| 07/19/2012 | US20120184579 Quinolines and Their Therapeutic Use |
| 07/19/2012 | US20120184572 Aryl gpr119 agonists and uses thereof |
| 07/19/2012 | US20120184556 Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators |
| 07/19/2012 | US20120184553 Novel compounds |
| 07/19/2012 | US20120184549 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 07/19/2012 | US20120184548 Carboxylic acid aryl amides |
| 07/19/2012 | US20120184544 Substituted benzamide derivatives as glucokinase (gk) activators |
| 07/19/2012 | US20120184540 1,4 oxazines as bace1 and/or bace2 inhibitors |
| 07/19/2012 | US20120184539 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders |
| 07/19/2012 | US20120184538 Isoxazolo-pyridine derivatives |
| 07/19/2012 | US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 07/19/2012 | US20120184523 C-Met Modulators and Method of Use |
| 07/19/2012 | US20120184520 Glycine compound |
| 07/19/2012 | US20120184518 Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitors |
| 07/19/2012 | US20120184516 sGC Stimulators |
| 07/19/2012 | US20120183522 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 07/19/2012 | US20120183498 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 07/19/2012 | US20120183496 Inhibitors of hepatitis c virus polymerase |
| 07/19/2012 | CA2824403A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea |
| 07/19/2012 | CA2824220A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders |
| 07/19/2012 | CA2824207A1 Crystalline oxazine derivative and its use as bace inhibitor |
| 07/19/2012 | CA2824097A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 07/18/2012 | EP2476671A1 1H-Quinazoline-2,4-diones |
| 07/18/2012 | EP2476669A1 Cyanoisoquinoline compounds and methods of use thereof |
| 07/18/2012 | EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 07/18/2012 | EP2475657A1 Inhibitors of flaviviridae viruses |
| 07/18/2012 | EP2475656A1 2, 3, 6 -triamino substituted pyridines as kv7 (kcnq) channel modulators |
| 07/18/2012 | EP2475654A1 Herbicidal pyrimidone derivatives |
| 07/18/2012 | EP2475653A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs |
| 07/18/2012 | EP2475642A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 07/18/2012 | EP2475428A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| 07/18/2012 | EP2475256A1 Hepatitis c virus inhibitors |
| 07/18/2012 | EP2475254A1 Hepatitis c virus inhibitors |
| 07/18/2012 | EP2296651B1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases |
| 07/18/2012 | EP2262772B1 Quinoline derivatives as axl kinase inhibitors |
| 07/18/2012 | EP1937669B9 Novel benzopyran derivatives as potassium channel openers |
| 07/18/2012 | EP1608648B1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 07/18/2012 | CN1753886B Process for producing acid adduct salt of polyacidic base compound |
| 07/18/2012 | CN102596947A Crystal forms of sulfonylurea compound and method for producing the same |
| 07/18/2012 | CN102596946A Antiviral compounds and methods of making and using thereof |
| 07/18/2012 | CN102596945A Ambipolar small molecule hosts for phosphorescent guest emitters |
| 07/18/2012 | CN102596944A Substituted piperidines |
| 07/18/2012 | CN102596943A Microbiocidal heterocycles |
| 07/18/2012 | CN102596941A Compounds for the treatment of dyslipidemia and related diseases |
| 07/18/2012 | CN102596939A Compounds for organic light emitting diode emissive layers |
| 07/18/2012 | CN102596938A Alkyl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 07/18/2012 | CN102596936A Antiviral compounds |
| 07/18/2012 | CN102596933A Herbicidal pyrimidone derivatives |
| 07/18/2012 | CN102596932A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 07/18/2012 | CN102596910A Androgen receptor modulating compounds |
| 07/18/2012 | CN102596909A Positive allosteric modulators (PAM) |
| 07/18/2012 | CN102596906A Use of indole derivatives as NURR-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 07/18/2012 | CN102584813A Compouds and uses thereof in modulating amyloid beta |
| 07/18/2012 | CN102584801A One pot method asymmetric synthesis process of HIV reverse transcriptase inhibitor Efavirenz compound |
| 07/18/2012 | CN102584799A Aromatic nitrogenous six-membered ring compounds |
| 07/18/2012 | CN102584754A Fused aromatic compounds having anti-diabetic activity |
| 07/18/2012 | CN102584738A New technology for synthesizing rivaroxaban intermediate |